JYLAMVO

Generic: METHOTREXATE

Manufacturer: Shorla Oncology Inc.

Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]Vitamin C [EPC]Vitamin B12 [EPC]
403,372
Total Reports
129,045
Serious Reports
32,412
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.04%)

Patient Demographics

Male
106,109
Female
254,336

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for JYLAMVO.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 74,382
11.8%
2 RHEUMATOID ARTHRITIS 37,727
6.0%
3 ARTHRALGIA 35,862
5.7%
4 PAIN 35,009
5.5%
5 OFF LABEL USE 33,274
5.3%
6 FATIGUE 28,758
4.6%
7 NAUSEA 23,657
3.7%
8 JOINT SWELLING 22,104
3.5%
9 HEADACHE 20,621
3.3%
10 RASH 19,659
3.1%
11 DRUG INTOLERANCE 19,503
3.1%
12 CONDITION AGGRAVATED 19,469
3.1%
13 DIARRHOEA 18,051
2.9%
14 PAIN IN EXTREMITY 17,675
2.8%
15 PYREXIA 16,839
2.7%
16 PNEUMONIA 15,996
2.5%
17 MALAISE 14,902
2.4%
18 VOMITING 14,889
2.4%
19 ALOPECIA 14,499
2.3%
20 TREATMENT FAILURE 14,419
2.3%
21 DYSPNOEA 14,282
2.3%
22 NASOPHARYNGITIS 13,982
2.2%
23 ABDOMINAL DISCOMFORT 13,974
2.2%
24 INJECTION SITE PAIN 13,743
2.2%
25 INFECTION 13,373
2.1%
26 ARTHROPATHY 13,131
2.1%
27 PERIPHERAL SWELLING 13,130
2.1%
28 CONTRAINDICATED PRODUCT ADMINISTERED 12,934
2.0%
29 MUSCULOSKELETAL STIFFNESS 12,846
2.0%
30 DRUG HYPERSENSITIVITY 12,344
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.